Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Type 2 diabetes and cognitive dysfunction—towards effective management of both comorbidities
Velandai Srikanth, Alan J. Sinclair, Felicia Hill‐Briggs, et al.
The Lancet Diabetes & Endocrinology (2020) Vol. 8, Iss. 6, pp. 535-545
Closed Access | Times Cited: 313

Showing 1-25 of 313 citing articles:

Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Melanie J. Davies, Vanita R. Aroda, Billy S. Collins, et al.
Diabetes Care (2022) Vol. 45, Iss. 11, pp. 2753-2786
Open Access | Times Cited: 1158
Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Melanie J. Davies, Vanita R. Aroda, Billy S. Collins, et al.
Diabetologia (2022) Vol. 65, Iss. 12, pp. 1925-1966
Open Access | Times Cited: 680
The impact of diabetes on cognitive impairment and its progression to dementia
Abigail Dove, Ying Shang, Weili Xu, et al.
Alzheimer s & Dementia (2021) Vol. 17, Iss. 11, pp. 1769-1778
Closed Access | Times Cited: 154
Extracellular vesicles mediate the communication of adipose tissue with brain and promote cognitive impairment associated with insulin resistance
Jin Wang, Liang Li, Zhou Zhang, et al.
Cell Metabolism (2022) Vol. 34, Iss. 9, pp. 1264-1279.e8
Open Access | Times Cited: 130
Cognitive impairment and type 2 diabetes mellitus: Focus of SGLT2 inhibitors treatment
Maria Rosaria Rizzo, Irene Di Meo, Rita Polito, et al.
Pharmacological Research (2022) Vol. 176, pp. 106062-106062
Open Access | Times Cited: 109
Type 2 diabetes mellitus-associated cognitive dysfunction: Advances in potential mechanisms and therapies
Ailin Luo, Zheng Xie, Yue Wang, et al.
Neuroscience & Biobehavioral Reviews (2022) Vol. 137, pp. 104642-104642
Closed Access | Times Cited: 84
Cognitive Impairment in Patients With Cardiac Disease: Implications for Clinical Practice
Astrid C. van Nieuwkerk, Ronak Delewi, Frank J. Wolters, et al.
Stroke (2023) Vol. 54, Iss. 8, pp. 2181-2191
Closed Access | Times Cited: 52
Effects of Tai Chi Chuan on Cognitive Function in Adults 60 Years or Older With Type 2 Diabetes and Mild Cognitive Impairment in China
Yannan Chen, Jiawei Qin, Liyuan Tao, et al.
JAMA Network Open (2023) Vol. 6, Iss. 4, pp. e237004-e237004
Open Access | Times Cited: 49
Synergistically effects of n-3 PUFA and B vitamins prevent diabetic cognitive dysfunction through promoting TET2-mediated active DNA demethylation
Lei Chen, Run Liu, Xiaoying He, et al.
Clinical Nutrition (2025) Vol. 45, pp. 111-123
Closed Access | Times Cited: 2
Neurobiological After-Effects of Low Intensity Transcranial Electric Stimulation of the Human Nervous System: From Basic Mechanisms to Metaplasticity
Sohaib Ali Korai, Federico Ranieri, Vincenzo Di Lazzaro, et al.
Frontiers in Neurology (2021) Vol. 12
Open Access | Times Cited: 58
Correlation of physical and cognitive impairment in diabetic and hypertensive frail older adults
Pasquale Mone, Jessica Gambardella, Angela Lombardi, et al.
Cardiovascular Diabetology (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 56
Molecular mechanisms underlying hyperglycemia associated cognitive decline
Mrinal Gupta, Shivani Pandey, Mohammad Rumman, et al.
IBRO Neuroscience Reports (2022) Vol. 14, pp. 57-63
Open Access | Times Cited: 53
Association between Type 2 Diabetes Mellitus and Brain Atrophy: A Meta-Analysis
Tianqi Zhang, Marnie Shaw, Nicolas Cherbuin
Diabetes & Metabolism Journal (2022) Vol. 46, Iss. 5, pp. 781-802
Open Access | Times Cited: 49
Cardiometabolic multimorbidity and incident dementia: the Swedish twin registry
Abigail Dove, Jie Guo, Anna Marseglia, et al.
European Heart Journal (2022) Vol. 44, Iss. 7, pp. 573-582
Open Access | Times Cited: 49
Type 2 diabetes mellitus and cognitive function: understanding the connections
Lisa Dao, Sarah Choi, Matthew Freeby
Current Opinion in Endocrinology Diabetes and Obesity (2022) Vol. 30, Iss. 1, pp. 7-13
Closed Access | Times Cited: 44
The Role of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RA) in Diabetes-Related Neurodegenerative Diseases
Dihe Cheng, Shuo Yang, Xue Zhao, et al.
Drug Design Development and Therapy (2022) Vol. Volume 16, pp. 665-684
Open Access | Times Cited: 43
Inside the diabetic brain: Insulin resistance and molecular mechanism associated with cognitive impairment and its possible therapeutic strategies
Bhaskar Jyoti Dutta, Shamsher Singh, Sanket Seksaria, et al.
Pharmacological Research (2022) Vol. 182, pp. 106358-106358
Closed Access | Times Cited: 42
Hypoglycemic medicines in the treatment of Alzheimer’s disease: Pathophysiological links between AD and glucose metabolism
Yixuan Wang, Hao Hu, Xinyu Liu, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 36
Comparison on cognitive outcomes of antidiabetic agents for type 2 diabetes: A systematic review and network meta‐analysis
Sai Tian, Jiaxuan Jiang, Jin Wang, et al.
Diabetes/Metabolism Research and Reviews (2023) Vol. 39, Iss. 7
Closed Access | Times Cited: 31
The Growing Role of Technology in the Care of Older Adults With Diabetes
Elbert S. Huang, Alan J. Sinclair, Paul R. Conlin, et al.
Diabetes Care (2023) Vol. 46, Iss. 8, pp. 1455-1463
Open Access | Times Cited: 30
The gut microbiota‐astrocyte axis: Implications for type 2 diabetic cognitive dysfunction
Zi-han Li, Yayi Jiang, Caiyi Long, et al.
CNS Neuroscience & Therapeutics (2023) Vol. 29, Iss. S1, pp. 59-73
Open Access | Times Cited: 28
The Role of PGC-1α-Mediated Mitochondrial Biogenesis in Neurons
Mengjie Chen, Ru-Yu Yan, Jian-Sheng Luo, et al.
Neurochemical Research (2023) Vol. 48, Iss. 9, pp. 2595-2606
Closed Access | Times Cited: 27
Insulin-degrading enzyme: Roles and pathways in ameliorating cognitive impairment associated with Alzheimer's disease and diabetes
Yue Tian, Guangchan Jing, Mengren Zhang
Ageing Research Reviews (2023) Vol. 90, pp. 101999-101999
Open Access | Times Cited: 26
The impact of diabetes in cognitive impairment: A review of current evidence and prospects for future investigations
Nicholas Aderinto, Gbolahan Olatunji, Muili Abdulbasit, et al.
Medicine (2023) Vol. 102, Iss. 43, pp. e35557-e35557
Open Access | Times Cited: 25
Longitudinal Change in Serum Neurofilament Light Chain in Type 2 Diabetes and Early Diabetic Polyneuropathy: ADDITION-Denmark
Laura L. Määttä, Signe T. Andersen, Tina Parkner, et al.
Diabetes Care (2024) Vol. 47, Iss. 6, pp. 986-994
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top